EP2285241A1 - Lasalocid compositions and methods - Google Patents
Lasalocid compositions and methodsInfo
- Publication number
- EP2285241A1 EP2285241A1 EP09759172A EP09759172A EP2285241A1 EP 2285241 A1 EP2285241 A1 EP 2285241A1 EP 09759172 A EP09759172 A EP 09759172A EP 09759172 A EP09759172 A EP 09759172A EP 2285241 A1 EP2285241 A1 EP 2285241A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- animal feed
- feed additive
- lasalocid
- additive composition
- carrier
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
- A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/111—Aromatic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K40/00—Shaping or working-up of animal feeding-stuffs
- A23K40/10—Shaping or working-up of animal feeding-stuffs by agglomeration; by granulation, e.g. making powders
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
Definitions
- Coccidiosis is an intestinal disease that affects several animal species, presenting a particularly important problem in the raising of poultry and cattle.
- Coccidiosis is primarily a disease of the young where there is crowding, stress, and/or nonimmune animals. Older cows act as a reservoir and shed oocysts into the environment. Shipping, weaning, dietary changes, and steroid therapy can precipitate Coccidiosis. Even cattle immune to their own endemic species of coccidia can become ill when exposed to different species. Coccidiosis may result in death.
- the causative agent of coccidiosis is a protozoan that has the ability to rapidly multiply. Damage is incurred by the rapid multiplication of the parasite in, aud the subsequent rupture of, cells of the intestinal lining.
- Eimeria zuemii and Eimeria bovis are the most frequently isolated species associated with the disease.
- Bovine coccidia undergo various stages of development. Infection gives rise to a microscopic egg (called an oocyst), which is passed out in manure. Under proper conditions, the oocyst develops within three to seven days to form a sporulate oocyst, which is capable of infecting other cattle.
- the sporulated oocyst contains eight bodies (called sporozoites), each of which is capable of entering a cell in the animal's intestine. When sporozoites enter intestinal cells, they divide several times, and each resulting offspring is capable of entering another intestinal cell. Male and female cells are produced. The male fertilizes the female to produce an oocyst, which in turn ruptures the intestinal cell and is passed in the manure. Thousands of oocysts maybe passed in the manure of an infected animal.
- Lasalocid is an antibiotic that has been shown to prevent coccidiosis in chickens, turkeys, sheep, partridges, and rabbits. It is also used to control coccidiosis in cattle be an effective coccidiostatic and antibacterial agent.
- Animal feedstuff compositions containing a prophylactic level of lasalocid have been prepared by admixing the drug or a salt thereof with the feedst ⁇ ff directly or by admixing an additive containing the drug with the desired feedstuff
- Feed additives are normally prepared by admixing the drag or salt thereof, or a solution of the drag or a salt thereof w ' th an edible substrate such as corn cob grits, soybean feed, com meal or the like.
- lasalocid Is prepared by fermentation of oigamsrns such as Streptomyces.
- an animal feed additive composition comprising an effective amount of lasalocid sodium, a carrier, and a binder.
- Another embodiment includes the use of a lasalocid in the manufacture of a feed additive for preventing coecidiosis.
- the feed additive comprises an effective amount of lasalocid sodium, a carrier, a binder, and optionally a colorant.
- an animal feed composition comprises an animal foodstuff, and an effective amount of an animal feed additive composition comprising an effective amount of lasalocid sodium, a carrier, a binder, and optionally a colorant.
- a method of making an animal feed additive composition comprises forming a mixture comprising from 0.1 wt-% to 30 wt-% of lasalocid sodium, from 69.9 wt-% to 99.8 wt-% of a carrier, from 0.1 wt-% to 10 wt-% of a binder, and 0 wt-% to 5 wt-% of a colorant, wherein all amounts are based on the total weight of the animal feed additive composition; and granulating the mixture to form a granulate.
- a “feed additive” composition refers to a composition suitable for incorporation into the diet of an animal through incorporation into the animal's food and/or water.
- the animal feed additive is in the form of a granulate.
- Feed additive compositions are also referred to as feed "pre-mix" compositions.
- Lasalocid sodium is typically prepared by fermentation of Streptomyces, followed by extraction to produce a fermentation product containing 80% or more lasalocid sodium.
- the lasalocid sodium comprises from 0.1 wt-% to 30 wt-% of the total weight of the lasalocid animal feed additive composition, specifically from 12 wt-% to 24 wt-% lasalocid animal feed additive composition.
- the lasalocid animal feed additive composition also comprises a binder.
- binder is well known to those of skill in the art as an agent that holds the components of the formulation together. Suitable binders include, for example, sodium carboxymethylcellulose, hydroxypropylmethylcellulose, gelatin, polyvinylpyrrolidone (PVP), polyvinylalcohol, polyvinylether, hydroxypropylcellulose, potassium alginate, sodium alginate, ethyl cellulose, methylcellulose, microcrystalline cellulose, starch such as partially pregelatinized corn starch, and combinations comprising one or more of the foregoing binders.
- the binder comprises sodium carboxymethylcellulose.
- the binder comprises from 0.1 wt-% to 10 wt-% of the total weight of the lasalocid animal feed additive composition, specifically from 0.2 wt-% to 5 wt-% of the lasalocid animal feed additive composition.
- the lasalocid animal feed additive composition also comprises a carrier.
- suitable carriers include, for example, starch, sucrose, glucose, methyl cellulose, magnesium stcarate, dicalcium phosphate, calcium sulfate, calcium sulfate dehydrate, mannitol, sorbitol, calcium carbonate, and combinations comprising one or more of the foregoing carriers.
- the carrier comprises calcium sulfate dihydrate.
- the carrier comprises from 69.9 wt-% to 99.8 wt-% wt-% of the total weight of the lasalocid animal feed additive composition, specifically from 79 wt-% to 87.7 wt-% of the lasalocid animal feed additive composition.
- the animal feed additive composition consists essentially of from 12 wt-% to 24 wt-% of the lasalocid sodium, from 79 wt-% to 87.7 wt-% of calcium sulfate dihydrate, and from 0.2 wt-% to 5 wt-% of sodium carboxymethylcellulose, wherein all amounts are based on the total weight of the animal feed additive.
- the composition has a colorant in an amount ranging from about 0.01% to about 2%.
- a specific colorant is Brillant Blue No. 1.
- compositions optionally comprise additional agents such as anti-caking agents, flow agents and combinations thereof,
- the animal feed additive composition is a multiparticulate composition.
- the term multiparticulate is intended to refer broadly to small particles regardless of their composition or the manner in which they are formed.
- the particles generally aie of a mean diameter of about 150 to 850 ⁇ m.
- the lasalocid sodium, carrier and binder are granulated to form the animal feed additive composition.
- Granulation is a process by which relatively small particles are built up into larger granular particles.
- a liquid is used to increase the intermolecular forces between particles, leading to an enhancement in granular integrity, referred to as the "strength" of the granule.
- the strength of the granule is determined by the amount of liquid that is present in the interstitial spaces between the particles during the granulation process. Examples of liquids found to be effective wet- granulation liquids include water, ethanol, isopropyl alcohol and acetone.
- the components of the animal feed additive are formed into a mixture and the mixture is granulated to form the granulate.
- Several types of wet-granulation processes can be used to form lasalocid sodium- containing multiparticulates. Examples include fluidized bed granulation, rotary granulation and high-shear mixers.
- fluidized bed granulation air is used to agitate or "fluidize" particles of lasalocid sodium and/or carrier in a fluidizing chamber. The liquid is then sprayed into this fluidized bed, forming the granules.
- rotary granulation horizontal discs rotate at high speed, forming a rotating "rope" of lasalocid sodium and/or carrier particles at the walls of the gianulation vessel. The liquid is sprayed into this rope, forming the granules.
- High-shear mixers contain an agitator or impeller to mix the particles of lasalocid sodium and/or carrier.
- the liquid is sprayed Into the moving bed of particles, forming granules.
- all or a portion of the carrier can be dissolved into the liquid prior to spraying the liquid onto the particles.
- the steps of forming the liquid mixture and forming particles from the liquid mixture occur simultaneously.
- the particles are formed by extruding the liquid mixture into a solid mass followed by spheronizing or milling the mass.
- the liquid mixture which is in the form of a paste-like plastic suspension, is extruded through a perforated plate or die to fo ⁇ n a solid mass, often in the form of elongated, solid rods.
- This solid mass is then milled to form the multiparticulates.
- the solid mass is placed, with or without an intervening drying step, onto a rotating disk that has protrusions that break the material into multiparticulate spheres, spheroids, or rounded rods.
- the so-formed multiparticulates are then dried to remove any remaining liquid. This process is sometimes referred to in the pharmaceutical arts as an extrusion/spheronization process.
- a portion of the liquid is removed, typically in a drying step, thus forming the multiparticulates.
- at least 80% of the liquid is removed from the particles, more preferably at least 90%, and most preferably at least 95% of the liquid is removed from the particle during the drying step.
- the multiparticulates may also be made by a granulation process comprising the steps of (a) forming a solid mixture comprising lasalocid, a carrier, and a binder; and (b) granulating the solid mixture to form multiparticulates.
- a granulation process comprising the steps of (a) forming a solid mixture comprising lasalocid, a carrier, and a binder; and (b) granulating the solid mixture to form multiparticulates.
- granulation processes include dry granulation and melt granulation, both well known in the art. See Remington 's Pharmaceutical Sciences (18th Ed. 1990).
- roller compaction An example of a dry granulation process is roller compaction.
- the solid mixture is compressed between rollers.
- the rollers can be designed such that the resulting compressed material is in the form of small beads or pellets of the desired diameter.
- the compressed material is in the form of a ribbon that may be milled to for multiparticulates using methods well known in the art.
- melt granulation processes the solid mixture is fed to a gran ⁇ lator that has the capability of heating or melting the carrier.
- Equipment suitable for use in this process includes high-shear grarsulators and single or multiple screw extruders, such as those described above for melt-congeal processes.
- melt granulation processes the solid mixture is placed into the granulator and heated until the solid mixture agglomerates. The solid mixture is then kneaded or mixed until the desired particle size is attained. The so-formed granules are then cooled, removed from the granulator and sieved to the desired size fraction, thus forming the multiparticulates.
- the lasalocid animal feed additive compositions may be employed at any time for successfully protecting cattle, poultry or other target animals against coccidiosis.
- the animal feed additive compositions may find application in broiler farms or poultry rearing houses for pullets, where a high burden of infection is produced for the poultry population because of the permanent forms of the coccidia (oocysts) which are constantly being excreted in the droppings. Since the risk of a coccidiosis outbreak always exists under these circumstances, the lasalocid animal feed additive compositions may be employed, in the case of poultry, continuously and before the outbreak of coccidiosis.
- the lasalocid animal feed additive compositions may, however, also be administered during short time intervals, i.e., a few days.
- the lasalocid animal feed additive compositions may also be employed to control coccidiosis due to Eimeria bovis and Eimeria zuernii in cattle. Additionally, the lasalocid animal feed additive composition may be used to prevent coccidiosis due to Eimeria ovina, E. crandallis, E. ovinaoidalis, E.ninakohlyakimovae, E. parva, and E. intricate in sheep. The lasalocid animal feed additive compositions may also be used to prevent coccidiosis due to Eimeria meleagrimitis, E. gallopavonis, and E. adenoeides in t ⁇ ikeys, Eimeria legionensis in Chukar Partridges, and E. sitesdae in rabbits. The lasalocid animal feed additive compositions may further be used to improve weight gain and/or feed efficiency in animals.
- the administration of lasalocid animal feed additive compositions and methods for combating coccidiosis are carried out in the normal manner.
- an oral administration is primarily suitable.
- the lasalocid compositions may in this case be mixed with feedstuffs or with drinking water.
- the lasalocid concentrations in feedstufts or in drinking water may vary within certain limits, in general between 3 and 10 ppm of the lasalocid in the feedstuff or drinking water.
- the lasalocid sodium concentrations of the coccidiocidal agents are based on the feed or drinking water preparations ad lib, i.e., for free feed or drinking water consumption during a normal practical fattening or rearing period. Because of special factors due to practical conditions, it may however happen that the cattle or poultry expert has to adjust these applied concentrations upwards if the poultry have to be supplied with different feed or water stocks. In that case, however, only a portion of the feed or water stocks contain lasalocid.
- Manufactured foodstuffs for animals such as cattle, pigs, and fowl are usually provided in the form of pellets or similar particulate material.
- Pellets are typically manufactured by combining a DCeal base with ingredients such as oil and protein, steam conditioning the mixture (for example at 70 0 C for 5 minutes), extruding through a circular die (typically between 2 mm and 15 mm in diameter), cutting into appropriately sized lengths (e.g., 5-20 mm), and drying.
- the finished pellets are generally cylindrically shaped and have a relatively smooth surface.
- an animal feed composition is prepared by adding a lasalocid animal feed additive composition to an animal foodstuff.
- the lasalocid animal feed additive composition may be added to the food in a number of ways.
- the lasalocid animal feed additive composition containing a given quantity of lasalocid may be added to a given quantity of feed and mixed or blended to provide a substantially homogeneous medicated feed composition. Large feed lots may be prepared in this manner for treating a large number of animals.
- feed batches containing feed for a single animal or single meal may be prepared either by mixing a predetermined quantity of lasalocid animal feed additive composition with the animal feed or by adding a predetermined quantity of premix to an animal's feed as a top dressing.
- the treatment method can also be extended to other methods for treating and feeding animals.
- the lasalocid animal feed additive compositions may be combined with other active substances, such as, for example, with other anti- coccidiodal agents, growth-promoting agents, antiparasitics, or antibiotics.
- a preferred combination is lasalocid sodium and chlortetracycline.
- the invention also includes a method for treating coccidiosis in animals such as cattle or poultry, wherein the lasalocid animal feed additive compositions are administered orally ad lib, and in particular, either as feedstuff or by means of drinking water.
- Tne invention is further illustrated by the following non-limiting examples.
- Lasalocid Sodium (alpha as is), 20.0 %; Sodium carboxymethylcellulose, 2.0 %; Brillant Blue Colorant Dualake FD&C, 0.05 % CaSO4 • 2 H 2 O (QSP 100.0 %), to 100 %.
- the amount of lasalocid sodium was determined by HPLC Test Method TCA-020.
- the stability data for the test batch formulations are shown in Tables 1 to 3. As can be seen from Tables 1 to 3, through 6 months the lasalocid animal feed additive is stable.
- Advantages of the animal feed additives disclosed herein are good particle size distribution, flowability, and stability.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Animal Husbandry (AREA)
- Birds (AREA)
- Fodder In General (AREA)
- Feed For Specific Animals (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5835108P | 2008-06-03 | 2008-06-03 | |
| PCT/US2009/045834 WO2009149011A1 (en) | 2008-06-03 | 2009-06-01 | Lasalocid compositions and methods |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP2285241A1 true EP2285241A1 (en) | 2011-02-23 |
| EP2285241A4 EP2285241A4 (en) | 2012-02-29 |
Family
ID=41398462
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP09759172A Withdrawn EP2285241A4 (en) | 2008-06-03 | 2009-06-01 | Lasalocid compositions and methods |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP2285241A4 (en) |
| AU (1) | AU2009256444B2 (en) |
| MY (1) | MY162336A (en) |
| WO (1) | WO2009149011A1 (en) |
| ZA (1) | ZA201008384B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107469074A (en) * | 2017-08-18 | 2017-12-15 | 中农威特生物科技股份有限公司 | A kind of chicken coccidiasis work egg capsule vaccine suspending agent |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH596305A5 (en) * | 1974-04-02 | 1978-03-15 | Hoffmann La Roche | |
| US3932637A (en) * | 1974-07-22 | 1976-01-13 | Sumitomo Chemical Company, Limited | Methods and compositions for improving the feed intake of meat producing animals |
| US4218438A (en) * | 1979-02-14 | 1980-08-19 | Eli Lilly And Company | Anticoccidial combinations comprising nicarbazin and the polyether antibiotics |
| DE3703789A1 (en) * | 1987-02-07 | 1988-08-18 | Hoechst Ag | COCCIDIOCIDE MEDIUM |
| US5300297A (en) * | 1991-01-14 | 1994-04-05 | Ajinomoto Co., Inc. | Feed additive for ruminants |
| AUPM430894A0 (en) * | 1994-03-08 | 1994-03-31 | Eli Lilly And Company | A formulation and methods of treatment (1) |
| US5646135A (en) * | 1994-10-18 | 1997-07-08 | Merck & Co., Inc. | Method for controlling coccidiosis |
-
2009
- 2009-06-01 MY MYPI2010005155A patent/MY162336A/en unknown
- 2009-06-01 AU AU2009256444A patent/AU2009256444B2/en not_active Ceased
- 2009-06-01 WO PCT/US2009/045834 patent/WO2009149011A1/en not_active Ceased
- 2009-06-01 EP EP09759172A patent/EP2285241A4/en not_active Withdrawn
-
2010
- 2010-11-23 ZA ZA2010/08384A patent/ZA201008384B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2285241A4 (en) | 2012-02-29 |
| AU2009256444A1 (en) | 2009-12-10 |
| ZA201008384B (en) | 2012-01-25 |
| AU2009256444B2 (en) | 2015-09-03 |
| MY162336A (en) | 2017-06-15 |
| WO2009149011A1 (en) | 2009-12-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20090053317A1 (en) | Microparticulate systems for the oral administration of biologically active substances | |
| CN101065024A (en) | Compositions and methods for promoting weight gain and feed conversion | |
| JP2021526848A (en) | Lumen Bypass Choline Chloride Microcapsules and Their Manufacturing Methods | |
| JP2007191488A (en) | How to treat fish parasites with emamectin | |
| WO2008123898A1 (en) | Maduramicin compositions and methods | |
| WO2004039172A1 (en) | Oral veterinary drug delivery system and/or feed additive delivery system, process for the preparation and use thereof | |
| AU2009277180B2 (en) | Laidlomycin compositions and methods | |
| AU2009256444B2 (en) | Lasalocid compositions and methods | |
| MXPA04001632A (en) | Composition with multiple uses for poultry. | |
| WO2009149012A1 (en) | Laidlomycin compositions and methods | |
| AU773316B2 (en) | Methods for reducing mortality rates in poultry | |
| EP2007367B1 (en) | Medicated feed premix comprising chlortetracycline hydrochloride | |
| KR20240028488A (en) | Use of furancarboxylic acid compounds in the manufacture of additives for animal feed | |
| US20080044516A1 (en) | Granules of Hydrophilic Active Principle | |
| EP0272119A2 (en) | Stable antibiotic ester feed compositions | |
| US8652547B2 (en) | Process for preparing granules of hydrophilic active principle by extrusion | |
| WO2009023014A1 (en) | Emamectin compositions and methods | |
| CN105360623A (en) | Application of hop acid-beta-cyclodextrin inclusion compound in preparation of animal feed additives | |
| JPH0550257B2 (en) | ||
| WO2002045751A1 (en) | Compositions for the treatment of coccidiosis | |
| JPS62155051A (en) | Method for feeding domestic animal and feed used therein | |
| HK1113974A (en) | Compositions and methods for promoting weight gain and feed conversion | |
| BG100673A (en) | Application of balchemicine for increasing animal productivity and compositions increasing the productivity |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20101202 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR |
|
| AX | Request for extension of the european patent |
Extension state: AL BA RS |
|
| DAX | Request for extension of the european patent (deleted) | ||
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20120130 |
|
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: A23L 1/30 20060101AFI20120124BHEP |
|
| RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: ZOETIS PRODUCTS LLC |
|
| 17Q | First examination report despatched |
Effective date: 20160614 |
|
| RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: ZOETIS SERVICES LLC |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20180518 |